RhIGF-1 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
156レット症候群2

156. レット症候群


臨床試験数 : 44 薬物数 : 61 - (DrugBank : 23) / 標的遺伝子数 : 57 - 標的パスウェイ数 : 83
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01777542
(ClinicalTrials.gov)
January 201323/1/2013Treatment of Rett Syndrome With Recombinant Human IGF-1Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)Rett SyndromeDrug: Recombinant Human Insulin Growth Factor 1 (rhIGF-1);Drug: PlaceboBoston Children's HospitalInternational Rett Syndrome FoundationCompleted2 Years10 YearsFemale30Phase 2United States
2NCT01253317
(ClinicalTrials.gov)
December 20102/12/2010Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With IGF-1Rett SyndromeDrug: rhIGF-1Boston Children’s HospitalInternational Rett Syndrome Foundation;Autism SpeaksCompleted2 Years12 YearsFemale12Phase 1United States